IP Library › Granted Patent US 9,788,712
Granted Patent B2
US 9,788,712 · App. 13/882,236 · Granted Oct 17, 2017

Device and method for determining the presence of middle ear fluid

Inventors: Rahul Seth (Los Angeles, CA); Matthew R. Ford (Bay Village, OH); Andrew M. Rollins (Highland Hts., OH); Paul K. Krakovitz (Shaker Hts., OH)
Assignee: The Cleveland Clinic Foundation
A61B1/227A61B1/063A61B1/0638A61B5/0075A61B5/0084A61B5/12A61B5/6817
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,788,712
App. No.
13/882,236
Granted
Oct 17, 2017
Kind
B2
Abstract

A device for determining the presence of abnormal fluid in a middle ear of a subject includes an elongated probe, a first light source housed within the elongated probe, and a second light source housed within the elongated probe. The elongated probe includes a distal end for inspection of an ear. The First light source is configured to convey an optical beam through a tympanic membrane associated with the middle ear of the subject, without puncturing the tympanic membrane. The second light source is configured to convey light through the distal end of the elongated probe and illuminate the tympanic membrane.

Claims (14)

1. A method for determining the presence of abnormal fluid in a middle ear of a subject, said method comprising the steps of:

providing a device comprising an elongated probe having a distal end configured for inspection of an ear of the subject, a first light source housed within the elongated probe and configured to operate at a low power;

activating the first light source to convey an optical beam through the tympanic membrane without puncturing the tympanic membrane; and

creating a reflectance pattern associated with the tympanic membrane based on the optical beam; and

observing the reflectance pattern through the device;

wherein a substantially diffuse reflectance pattern indicates the presence of abnormal fluid in the middle ear of the subject.

2. The method of claim 1 , wherein a substantially concentrated reflectance pattern indicates the absence of abnormal fluid in the middle ear of the subject.

3. The method of claim 1 , wherein said step of providing a device further includes providing a second light source that is housed within the elongated probe and configured to illuminate the tympanic membrane;

wherein the second light source comprises an incandescent light source.

4. The method of claim 1 , wherein the low power is less than about 10 mW.

5. The method of claim 1 , wherein the low power is less than about 5 mW.

6. The method of claim 1 , wherein said step of activating the first light source further comprises activating the first light source to convey a coherent optical beam having a wavelength of about 532 nm.

7. The method of claim 1 , wherein said step of activating the first light source further comprises activating the first light source to convey a coherent optical beam having a wavelength of about 635 nm.

8. The method of claim 1 , wherein the first light source comprises a low power light source selected from the group consisting of a LED, a laser, and a laser diode.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2013
From: ROLLINS, ANDREW M.
To: CASE WESTERN RESERVE UNIVERSITY
Reel/Frame 030832/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2013
From: SETH, RAHUL; FORD, MATTHEW R.; KRAKOVITZ, PAUL R.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 030832/0657 →
Continuity (2)
Provisional Application 61410114 · Nov 4, 2010
Related Publication 20130289353A1 · Oct 31, 2013